(Q36677236)

15 August 2017

An unholy alliance: cooperation between BRAF and NF1 in melanoma development and BRAF inhibitor resistance (English)

1 reference

15 August 2017

1 reference

2

Keiran S M Smalley

1 reference

15 August 2017

Geoffrey T Gibney

1

1 reference

15 August 2017

1 March 2013

1 reference

15 August 2017

1 reference

15 August 2017

3

1 reference

15 August 2017

3

1 reference

15 August 2017

260-263

1 reference

Elucidating distinct roles for NF1 in melanomagenesis

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595124

Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595124

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595124

Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595124

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595124

Acquired and intrinsic BRAF inhibitor resistance in BRAF V600E mutant melanoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595124

Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595124

The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595124

BRAFE600-associated senescence-like cell cycle arrest of human naevi

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595124

Mutations of the BRAF gene in human cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595124

NF1 tumor suppressor gene function: narrowing the GAP

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595124

Breast cancer and other neoplasms in women with neurofibromatosis type 1: a retrospective review of cases in the Detroit metropolitan area

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595124

Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines

20 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23475878

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Neurofibromin as a regulator of melanocyte development and differentiation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23475878

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/2159-8290.CD-13-0017

1 reference

15 August 2017

1 reference

15 August 2017

1 reference

PMCID

3595124